Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.

MLA

Faber, Lothar, et al. “Percutaneous Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: Managing the Risk of Procedure-Related AV Conduction Disturbances.” International Journal of Cardiology, vol. 119, no. 2, July 2007, pp. 163–67. EBSCOhost, https://doi.org/10.1016/j.ijcard.2006.07.179.

APA

Faber, L., Welge, D., Fassbender, D., Schmidt, H. K., Horstkotte, D., & Seggewiss, H. (2007). Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. International Journal of Cardiology, 119(2), 163–167. https://doi.org/10.1016/j.ijcard.2006.07.179

Chicago

Faber, Lothar, Dirk Welge, Dieter Fassbender, Henning K Schmidt, Dieter Horstkotte, and Hubert Seggewiss. 2007. “Percutaneous Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: Managing the Risk of Procedure-Related AV Conduction Disturbances.” International Journal of Cardiology 119 (2): 163–67. doi:10.1016/j.ijcard.2006.07.179.